| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |